| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AR-1 | USD | 305.000 | 6.20 | Aaa | AAA | - | - | - | 39.00% | - | Floating | 3mL | 113 | 113 | 3mL+113 | - | - |
| AR-2 | USD | 15.000 | 7.80 | Aaa | NR | - | - | - | 36.00% | - | Floating | 3mL | - | 135 | 3mL+135 | - | - |
| BR | USD | 60.000 | 8.30 | NR | AA | - | - | - | 24.00% | - | Floating | 3mL | 160-165 | 170 | 3mL+170 | - | - |
| CR | USD | 27.500 | 8.90 | NR | A | - | - | - | 18.50% | - | Floating | 3mL | 190-200 | 210 | 3mL+210 | - | - |
| DR | USD | 32.500 | 9.50 | NR | BBB- | - | - | - | 12.00% | - | Floating | 3mL | 300a | 315 | 3mL+315 | - | - |
| ER | USD | 17.500 | 9.90 | NR | BB- | - | - | - | 8.50% | - | Floating | 3mL | - | 635 | 3mL+635 | - | - |
| Sub | USD | 41.500 | - | NR | NR | - | - | - | - | - | - | - | - | - | - | - | Retained |
Explore all other research.